Regarding DSCs as simple as changing dissolvement from plasma to albumin, significantly improved cell viability and also outcome in steroid-refractory acute GVHD.92 Similar improvements in culture conditionings or priming also may have improved the treatment of acute GVHD using other sources such as BM-MSCs and with MSCs from adipose, cord blood, cord, crude, placenta, or fat. This evidence concerns the gene ALB and acute graft versus host disease.